Abbott to pay $56 in cash per share for Alere; terms amended to $51 per share
Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc.
- In Vitro Diagnostics
- Medical Devices
- OTC, Consumer
In Vitro Diagnostics
- Chemistry, Immunoassay
- Glucose Testing
- Urine-based Testing
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.